Judson I - Search Results

1

The clinical applications of heat shock protein inhibitors in cancer - present and future.

Banerji U, Judson I, Workman P. Banerji U, et al. Among authors: judson i. Curr Cancer Drug Targets. 2003 Oct;3(5):385-90. doi: 10.2174/1568009033481813. Curr Cancer Drug Targets. 2003. PMID: 14529390 Review.

2

The anthrapyrazoles: a new class of compounds with clinical activity in breast cancer.

Judson IR. Judson IR. Semin Oncol. 1992 Dec;19(6):687-94. Semin Oncol. 1992. PMID: 1462167 Review.

3

Understanding anticancer drug resistance: opportunities for modulation and impact on new drug design.

Judson IR. Judson IR. Eur J Cancer. 1992;28(1):285-9. doi: 10.1016/0959-8049(92)90435-5. Eur J Cancer. 1992. PMID: 1567681 Review.

4

Anthrapyrazoles: true successors to the anthracyclines?

Judson IR. Judson IR. Anticancer Drugs. 1991 Jun;2(3):223-31. Anticancer Drugs. 1991. PMID: 1802016 Review.

5

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.

Powles TJ, Jones AL, Judson IR, Hardy JR, Ashley SE. Powles TJ, et al. Among authors: judson ir. Br J Cancer. 1991 Aug;64(2):406-10. doi: 10.1038/bjc.1991.318. Br J Cancer. 1991. PMID: 1892775 Free PMC article. Clinical Trial.

6

ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

Jackman AL, Taylor GA, Gibson W, Kimbell R, Brown M, Calvert AH, Judson IR, Hughes LR. Jackman AL, et al. Among authors: judson ir. Cancer Res. 1991 Oct 15;51(20):5579-86. Cancer Res. 1991. PMID: 1913676

7

Phase II trial of trimelamol in refractory ovarian cancer.

Judson IR, Calvert AH, Gore ME, Balmanno K, Gumbrell LA, Perren T, Wiltshaw E. Judson IR, et al. Br J Cancer. 1991 Feb;63(2):311-3. doi: 10.1038/bjc.1991.72. Br J Cancer. 1991. PMID: 1997112 Free PMC article. Clinical Trial.

8

The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancer.

Hardy J, Smith I, Cherryman G, Vincent M, Judson I, Perren T, Williams M. Hardy J, et al. Among authors: judson i. Br J Cancer. 1990 Oct;62(4):684-6. doi: 10.1038/bjc.1990.357. Br J Cancer. 1990. PMID: 2171623 Free PMC article.

9

New endocrine agents, guidelines for future development.

Judson IR. Judson IR. Br J Cancer. 1989 Aug;60(2):153-4. doi: 10.1038/bjc.1989.240. Br J Cancer. 1989. PMID: 2669919 Free PMC article. Review. No abstract available.

10

Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).

Judson IR, Calvert AH, Rutty CJ, Abel G, Gumbrell LA, Graham MA, Evans BD, Wilman DE, Ashley SE, Cairnduff F. Judson IR, et al. Cancer Res. 1989 Oct 1;49(19):5475-9. Cancer Res. 1989. PMID: 2670205 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results